Market Overview:
The global particle therapy market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of cancer, technological advancements in particle therapy, and rising demand for minimally invasive treatments. Based on type, the proton therapy segment is expected to account for the largest share of the global particle therapy market in 2018. This segment is projected to grow at a CAGR of 11% from 2018 to 2030. The large share of this segment can be attributed to its advantages over other types of radiation therapies such as X-rays and gamma rays. Proton therapy delivers high-energy protons directly into tumors, which results in less damage to surrounding healthy tissues than other forms of radiation therapies. Based on application, pediatric cancer accounted for the largest share of the global particle therapy market in 2017 and it is projected that this trend will continue during the forecast period.
Product Definition:
Particle therapy is a radiation therapy technique that uses beams of protons or carbon ions to treat cancer. It is sometimes called proton beam therapy, proton therapy, or particle therapy. Particle therapy is important because it can deliver a higher dose of radiation to the tumor while sparing healthy tissue.
Proton Therapy:
Proton therapy is a type of particle therapy that uses high-energy protons to treat cancer. Protons are capable of causing more damage to the cancer cells than photons as they have greater energy. The advantage of proton over photon treatment is that there are very few, if any, side effects whereas with phototherapy the patients may experience nausea and fatigue.
Heavy Ion Therapy:
Heavy ion therapy is a type of particle therapy that utilizes high-energy ions to treat cancer. The heavy ions have greater energy and will damage the cancer cell more efficiently than normal ionic radiation. Heavy Ions are made up of atoms with large atomic number (Z) and higher mass numbers (number of protons). Protons have a positive charge while electrons have a negative charge. When combined, they make up an atom's electron cloud which gives it a net positive charge.
Application Insights:
The global market is segmented by application into pediatric cancer, prostate cancer, breast cancer, lung cancer, head and neck cancers other cancers. The other category includes osteosarcoma and Ewing¢â‚¬â„¢s tumor among others. Prostate cancer held the largest share in 2017 owing to factors such as increasing incidence rates of prostate carcinoma globally coupled with high treatment rate for this disease using particle therapy worldwide.
Pediatric oncology is expected to be the fastest-growing segment over the forecast period due to rising number of patients suffering from acute lymphoblastic leukemia (ALL). In addition, particle radiation therapy has proved itself as an effective method for treating children with ALL thus boosting industry growth across all regions.
Regional Analysis:
North America dominated the global particle therapy market in 2017. This can be attributed to the presence of major players, high adoption rate of advanced technologies, and availability of well-developed healthcare infrastructure. In addition, rising incidence rates for cancer is anticipated to boost the demand for proton therapy over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to increasing government initiatives and improving healthcare facilities in emerging countries such as India and China.
In 2016, Japan accounted for majority share followed by Germany due to better reimbursement scenario compared with other European countries along with growing awareness about proton therapy treatment among patients from other parts of Europe as well as from overseas centers such as Canada & U.S.
Growth Factors:
- Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. According to the World Health Organization (WHO), the number of new cases is expected to rise from 14 million in 2012 to 22 million by 2030. This will create a large pool of potential patients for particle therapy treatment.
- Growing awareness about particle therapy: There is growing awareness about the benefits of particle therapy among both doctors and patients. This is helping to drive demand for this treatment modality.
- Technological advancements: The technology used for particle therapy continues to evolve, offering improved efficacy and safety profile compared to traditional radiation therapies such as X-rays and gamma rays radiation therapies .
Scope Of The Report
Report Attributes
Report Details
Report Title
Particle Therapy Market Research Report
By Type
Proton Therapy, Heavy Ion Therapy
By Application
Pediatric Cancer, Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Other Cancers
By Companies
Varian Medical Systems, Ion Beam Applications Sa (IBA), Mevion Medical Systems, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., Hitachi, Ltd., Optivus Proton Therapy, Inc., Protom International, Inc., Advanced Oncotherapy PLC., Danfysik A/S
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
175
Number of Tables & Figures
123
Customization Available
Yes, the report can be customized as per your need.
Global Particle Therapy Market Report Segments:
The global Particle Therapy market is segmented on the basis of:
Types
Proton Therapy, Heavy Ion Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pediatric Cancer, Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Other Cancers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Varian Medical Systems
- Ion Beam Applications Sa (IBA)
- Mevion Medical Systems, Inc.
- Provision Healthcare, LLC
- Sumitomo Heavy Industries, Ltd.
- Hitachi, Ltd.
- Optivus Proton Therapy, Inc.
- Protom International, Inc.
- Advanced Oncotherapy PLC.
- Danfysik A/S
Highlights of The Particle Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Proton Therapy
- Heavy Ion Therapy
- By Application:
- Pediatric Cancer
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Head and Neck Cancer
- Other Cancers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Particle Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Particle therapy is a type of cancer treatment that uses tiny particles to destroy cancer cells. Particle therapy is often used in combination with other treatments, such as chemotherapy or radiation, to help kill the cancer.
Some of the key players operating in the particle therapy market are Varian Medical Systems, Ion Beam Applications Sa (IBA), Mevion Medical Systems, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., Hitachi, Ltd., Optivus Proton Therapy, Inc., Protom International, Inc., Advanced Oncotherapy PLC., Danfysik A/S.
The particle therapy market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Particle Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Particle Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Particle Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Particle Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Particle Therapy Market Size & Forecast, 2018-2028
4.5.1 Particle Therapy Market Size and Y-o-Y Growth
4.5.2 Particle Therapy Market Absolute $ Opportunity
Chapter 5 Global Particle Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Particle Therapy Market Size Forecast by Type
5.2.1 Proton Therapy
5.2.2 Heavy Ion Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Particle Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Particle Therapy Market Size Forecast by Applications
6.2.1 Pediatric Cancer
6.2.2 Prostate Cancer
6.2.3 Breast Cancer
6.2.4 Lung Cancer
6.2.5 Head and Neck Cancer
6.2.6 Other Cancers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Particle Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Particle Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Particle Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Particle Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Particle Therapy Market Size Forecast by Type
9.6.1 Proton Therapy
9.6.2 Heavy Ion Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Particle Therapy Market Size Forecast by Applications
9.10.1 Pediatric Cancer
9.10.2 Prostate Cancer
9.10.3 Breast Cancer
9.10.4 Lung Cancer
9.10.5 Head and Neck Cancer
9.10.6 Other Cancers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Particle Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Particle Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Particle Therapy Market Size Forecast by Type
10.6.1 Proton Therapy
10.6.2 Heavy Ion Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Particle Therapy Market Size Forecast by Applications
10.10.1 Pediatric Cancer
10.10.2 Prostate Cancer
10.10.3 Breast Cancer
10.10.4 Lung Cancer
10.10.5 Head and Neck Cancer
10.10.6 Other Cancers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Particle Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Particle Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Particle Therapy Market Size Forecast by Type
11.6.1 Proton Therapy
11.6.2 Heavy Ion Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Particle Therapy Market Size Forecast by Applications
11.10.1 Pediatric Cancer
11.10.2 Prostate Cancer
11.10.3 Breast Cancer
11.10.4 Lung Cancer
11.10.5 Head and Neck Cancer
11.10.6 Other Cancers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Particle Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Particle Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Particle Therapy Market Size Forecast by Type
12.6.1 Proton Therapy
12.6.2 Heavy Ion Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Particle Therapy Market Size Forecast by Applications
12.10.1 Pediatric Cancer
12.10.2 Prostate Cancer
12.10.3 Breast Cancer
12.10.4 Lung Cancer
12.10.5 Head and Neck Cancer
12.10.6 Other Cancers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Particle Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Particle Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Particle Therapy Market Size Forecast by Type
13.6.1 Proton Therapy
13.6.2 Heavy Ion Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Particle Therapy Market Size Forecast by Applications
13.10.1 Pediatric Cancer
13.10.2 Prostate Cancer
13.10.3 Breast Cancer
13.10.4 Lung Cancer
13.10.5 Head and Neck Cancer
13.10.6 Other Cancers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Particle Therapy Market: Competitive Dashboard
14.2 Global Particle Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Varian Medical Systems
14.3.2 Ion Beam Applications Sa (IBA)
14.3.3 Mevion Medical Systems, Inc.
14.3.4 Provision Healthcare, LLC
14.3.5 Sumitomo Heavy Industries, Ltd.
14.3.6 Hitachi, Ltd.
14.3.7 Optivus Proton Therapy, Inc.
14.3.8 Protom International, Inc.
14.3.9 Advanced Oncotherapy PLC.
14.3.10 Danfysik A/S
